Cargando…
Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders
Brain amyloid deposition is an early pathological event in Alzheimer’s disease (AD), and abnormally low levels amyloid-β(42) peptide (Aβ(42)) in cerebrospinal fluid (CSF) can be detected in preclinical AD. To identify the genetic determinants that regulate the rate of CSF Aβ(42) decline among non-de...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710044/ https://www.ncbi.nlm.nih.gov/pubmed/31370031 http://dx.doi.org/10.18632/aging.102125 |
_version_ | 1783446283558584320 |
---|---|
author | Dou, Kai-Xin Zhang, Can Tan, Chen-Chen Xu, Wei Li, Jie-Qiong Cao, Xi-Peng Tan, Lan Yu, Jin-Tai |
author_facet | Dou, Kai-Xin Zhang, Can Tan, Chen-Chen Xu, Wei Li, Jie-Qiong Cao, Xi-Peng Tan, Lan Yu, Jin-Tai |
author_sort | Dou, Kai-Xin |
collection | PubMed |
description | Brain amyloid deposition is an early pathological event in Alzheimer’s disease (AD), and abnormally low levels amyloid-β(42) peptide (Aβ(42)) in cerebrospinal fluid (CSF) can be detected in preclinical AD. To identify the genetic determinants that regulate the rate of CSF Aβ(42) decline among non-demented elders, we conducted a genome-wide association study involved 321 non-demented elders from Alzheimer’s Disease Neuroimaging Initiative (ADNI) 1/GO/2 cohorts restricted to non-Hispanic Caucasians. A novel genome-wide significant association of higher annualized percent decline of CSF Aβ(42) in the gene CBFA2T3 (CBFA2/RUNX1 translocation partner 3; rs13333659-T; p = 2.24 × 10(−9)) was identified. Besides displaying abnormal CSF Aβ(42) levels, rs13333659-T carriers were more likely to exhibit a greater longitudinal cognitive decline (p = 0.029, β = 0.097) and hippocampal atrophy (p = 0.029, β = −0.160) in the non-demented elders, especially for the participants who were amyloid-positive at baseline. These findings suggest rs13333659 in CBFA2T3 as a risk locus to modulate the decline rate of CSF Aβ(42) preceding the onset of clinical symptoms. |
format | Online Article Text |
id | pubmed-6710044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-67100442019-09-05 Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders Dou, Kai-Xin Zhang, Can Tan, Chen-Chen Xu, Wei Li, Jie-Qiong Cao, Xi-Peng Tan, Lan Yu, Jin-Tai Aging (Albany NY) Research Paper Brain amyloid deposition is an early pathological event in Alzheimer’s disease (AD), and abnormally low levels amyloid-β(42) peptide (Aβ(42)) in cerebrospinal fluid (CSF) can be detected in preclinical AD. To identify the genetic determinants that regulate the rate of CSF Aβ(42) decline among non-demented elders, we conducted a genome-wide association study involved 321 non-demented elders from Alzheimer’s Disease Neuroimaging Initiative (ADNI) 1/GO/2 cohorts restricted to non-Hispanic Caucasians. A novel genome-wide significant association of higher annualized percent decline of CSF Aβ(42) in the gene CBFA2T3 (CBFA2/RUNX1 translocation partner 3; rs13333659-T; p = 2.24 × 10(−9)) was identified. Besides displaying abnormal CSF Aβ(42) levels, rs13333659-T carriers were more likely to exhibit a greater longitudinal cognitive decline (p = 0.029, β = 0.097) and hippocampal atrophy (p = 0.029, β = −0.160) in the non-demented elders, especially for the participants who were amyloid-positive at baseline. These findings suggest rs13333659 in CBFA2T3 as a risk locus to modulate the decline rate of CSF Aβ(42) preceding the onset of clinical symptoms. Impact Journals 2019-08-01 /pmc/articles/PMC6710044/ /pubmed/31370031 http://dx.doi.org/10.18632/aging.102125 Text en Copyright © 2019 Dou et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Dou, Kai-Xin Zhang, Can Tan, Chen-Chen Xu, Wei Li, Jie-Qiong Cao, Xi-Peng Tan, Lan Yu, Jin-Tai Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders |
title | Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders |
title_full | Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders |
title_fullStr | Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders |
title_full_unstemmed | Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders |
title_short | Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders |
title_sort | genome-wide association study identifies cbfa2t3 affecting the rate of csf aβ(42) decline in non-demented elders |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710044/ https://www.ncbi.nlm.nih.gov/pubmed/31370031 http://dx.doi.org/10.18632/aging.102125 |
work_keys_str_mv | AT doukaixin genomewideassociationstudyidentifiescbfa2t3affectingtherateofcsfab42declineinnondementedelders AT zhangcan genomewideassociationstudyidentifiescbfa2t3affectingtherateofcsfab42declineinnondementedelders AT tanchenchen genomewideassociationstudyidentifiescbfa2t3affectingtherateofcsfab42declineinnondementedelders AT xuwei genomewideassociationstudyidentifiescbfa2t3affectingtherateofcsfab42declineinnondementedelders AT lijieqiong genomewideassociationstudyidentifiescbfa2t3affectingtherateofcsfab42declineinnondementedelders AT caoxipeng genomewideassociationstudyidentifiescbfa2t3affectingtherateofcsfab42declineinnondementedelders AT tanlan genomewideassociationstudyidentifiescbfa2t3affectingtherateofcsfab42declineinnondementedelders AT yujintai genomewideassociationstudyidentifiescbfa2t3affectingtherateofcsfab42declineinnondementedelders AT genomewideassociationstudyidentifiescbfa2t3affectingtherateofcsfab42declineinnondementedelders |